Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
While early safety data appear favorable, the potential for proangiogenic activity to influence oncogenic processes underscores the importance of comprehensive cancer pre-screening prior to therapeutic use
Integrative Peptides offers this product in a convenient oral formulation designed for professional use and manufactured under strict quality standards
Individual results may vary, and no outcomes are guaranteed
Research Results and Observations BPC-157 (Body Protection Compound-157) is widely studied in experimental regenerative models: Tissue repair: Although large placebo-controlled phase 3 human trials are lacking, in vivo and pilot studies have examined tendon, muscle, ligament, and bone healing
and hot flashes
Additionally, increased expression of FAk and paxillin was observed, suggesting that these proteins may play a role in mediating the recovery of injured tendons [11]
